Determination of sultamicillin in bulk and pharmaceutical preparations via derivatization with NBD-Cl by spectrophotometry

Abstract

Background and Aims: A new sensitive and selective method for the determination of sultamicillin in bulk and pharmaceutical preparations has been developed. Methods: The developed method is based on the derivatization of sultamicillin with 4-chloro-7-nitrobenzofurazan in pH 9.0 borate buffer at 70ºC for 60 min. The derivative was measured spectrophotometrically at 432 nm after extraction with chloroform. Results: The method was validated by linearity, LOD, LOQ, accuracy, precision and recovery parameters. The linear range for sultamicillin was 10-50 µg.mL-1 with a correlation coefficient of 0.9999. The limit of detection (LOD) and limit of quantification (LOQ) were found to be 1.47 and 4.41 µg/mL-1, respectively. Conclusion: The suggested method was validated, and can be applied for routine sultamicillin analysis in dosage formsfor industrial analysis.

Keywords

• 4-chloro-7-nitrobenzofurazan,sultamicillin,spectrophotometry,validation

References

1. • Ayad, M. M., Hosny, M. M., & Sharaf, Y. A. (2013). Application of 4-chloro-7-nitrobenzofurazan for the analysis of propafenone and diltiazem hydrochlorides using kinetic spectrophotometric and spectrofluorimetric methods. European Journal of Chemistry, 4(1), 35–43.
2. • Azza, H. R., Salwa, R. E., Gamal, A. S., & Fardous, A. M. (2010). Spectophotometric method for determination of certain cephalosporins using 4-chloro-7-nitrobenzo-2-oxa-1, 3-diazole (NBD-Cl). Natural Science, 2, 828–840.
3. • Bahrami, G., & Mohammadi, B. (2006). Sensitive microanalysis of gabapentin by high-performance liquid chromatography in human serum using pre-column derivatization with 4-chloro-7-nitrobenzofurazan: Application to a bioequivalence study. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 837, 24–28.
4. Table • Darwish, I., Mahmoud, A., Khalil, N. Y. (2008). Nonextractive Procedure and Precolumn Derivatization with 7-Chloro-4-nitrobenzo-2-oxa-1,3-diazole for Trace determination of trimetazidine in plasma by high-performance liquid chromatography with fluorescence detection. Journal-Association of Official Analytical Chemists, 91(5), 1037–1044.
5. • El-Emam, A. A., Hansen, S. H., Moustafa, M. A., El-Ashry, S. M., & El-Sherbiny, D. T. (2004). Determination of lisinopril in dosage forms and spiked human plasma through derivatization with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) followed by spectrophotometry or HPLC with fluorimetric detection. Journal of Pharmaceutical and Biomedical Analysis, 34, 35–44.
6. • El-Enany, N., Ahmida, N., & Bela, F. (2009). Spectrofluorimetric and spectrophotometric determination of oxamniquine in pharmaceuticals and biological fluids via derivatization with 7-chloro4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl). Journal- Chinese Chemical Society Taipei, 56, 485–492.
7. • El-Abd, H. S., Colyer, C. L., Hassan, W. S., & Shalaby, A. J. (2013). Utility of 4-chloro-7-nitrobenzofurazan (NBD-CI) for the Spectrophotometric and spectrofluorometric determination of several antihistamine and antihypertensive drugs. Journal-Association of Official Analytical Chemists, 96(5), 968–75.
8. • El-Shanawani, A. A. (1998). HPLC determination of sulbactam, sultamicillin tosylate, cefaclor, ampicillin and cefoperazone in pharmaceutical preparations. Acta Poloniae Pharmaceutica-Drug Research, 55(1), 15–19. European Pharmacopoeia, 6.0, 3003

9. • Farshchia, A., Ghiasia, G., & Bahramia, G. (2009). High Performance Liquid Chromatography Determination of Sertraline in Human. Iranian Journal of Pharmaceutical Sciences, 5(3), 171–178.
10. • Ganesh, B. G., Kalshetti, M. S., & Sanket, A. K. (2018). Analytical method development and validation for sultamicillin tosylate dihydrate in bulk and pharmaceutical dosage forms by RP-HPLC. International Journal for Pharmaceutical Research Scholars, 7, 1–2.
11. • International Conference on Harmonization. ICH. Validation of analytical procedures: text and methodology Q2 R1. Geneva: International Conference on Harmonization; 2005. [cited 2018 Mar 4] Available from: http://academy.gmp compliance.org/ guidemgr/files/Q2(R1).PDF
12. • Klimisch, H. J., & Stadler, L. (1974).Fluorimetric determination of nitrosamines after acid catalysed denitrification and obtaining of a derivative with 7 chloro 4 nitrobenzo 2 oxa 1,3 diazole. Journal of Chromatography A, 90, 223–225.
13. • Kshirsagar, S. A., Mane, S. B., Hanchate, Y. S., Katte, A. S., Rhumane, M. B., Mirza, N. N. … Mudke, R. P. (2018). UV spectrophotometrıc method development and validation for determination of sultamicillintosylate in API and in pharmaceutical dosage form. Australian Journal of Science and Technology, 9, 7657–7662.
14. • Laviana, L., Fernández, M. F., Bayod, M., & Blanco, D. (2003). HPLC for in-process control in the production of sultamicillin. Journal of Pharmaceutical and Biomedical Analysis,31(2), 321–328. • Murray, G. M., & Sepaniak, M. J. (1983). HPLC laser fluorometric determination of amines in beer. Journal of Liquid Chromatography, 6, 931–938.
15. • Olgun, N., Erturk, S., & Atmaca, S. (2002). Spectrofluorimetric and spectrophotometric methods for the determination of vigabatrin in tablets. Journal of Pharmaceutical and Biomedical Analysis, 29, 1–5.
16. • Pajchel, G., & Tyski, S. (2002). Application of micellar electrokinetic chromatography to the determination of sultamicillin in oral pharmaceutical preparations. Journal of Chromatography A, 979, 315–321.
17. • Shehata, M. A., El-Sayed, G. M., & Abdel-Fattah, L. E. (2006). Utilization of 4-chloro-7-nitro-2,1,3-benzoxadiazole (NBD-Cl) for kinetic spectrophotometric assay of befunolol hydrochloride in its pharmaceutical formulation. Journal - Association of Official Analytical Chemists, 89(3), 646–650.
18. • Taha, E. A., Salama, N. N., & Fattah, Lel-S. (2006). Spectrofluorimetric and spectrophotometric stability-indicating methods for determination of some oxicams using 7-chloro-4-nitrobenz2oxa-1,3-diazole (NBD-Cl). Chemical & Pharmaceutical Bulletin, 54, 653–658.
19. • Tatar-Ulu, S. (2007). Development of an HPLC method for the determination of mexiletine in human plasma and urine by solidphase extraction. Talanta, 72(3),1172–1177. • Tosunoglu, S., & Ersoy, L. (1995). Determination of baclofen in human plasma and urine by high-performance liquid chromatography with fluorescence detection. Analyst, 120, 373–375.
20. • Yılmaz, E. M., Aydoğmuş, Z., & Aboul-Eneın, H. Y. (2016). Determination of nilotinib in spiked plasma, urine, and capsules by highperformance liquid chromatography with fluorimetric detection. Acta Chromatographica, 28, 313–331.